These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25797830)

  • 1. Accelerated vs. unaccelerated serial MRI based TBM-SyN measurements for clinical trials in Alzheimer's disease.
    Vemuri P; Senjem ML; Gunter JL; Lundt ES; Tosakulwong N; Weigand SD; Borowski BJ; Bernstein MA; Zuk SM; Lowe VJ; Knopman DS; Petersen RC; Fox NC; Thompson PM; Weiner MW; Jack CR;
    Neuroimage; 2015 Jun; 113():61-9. PubMed ID: 25797830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual rating method and tensor-based morphometry in the diagnosis of mild cognitive impairment and Alzheimer's disease: a comparative magnetic resonance imaging study.
    Tuokkola T; Koikkalainen J; Parkkola R; Karrasch M; Lötjönen J; Rinne JO
    Acta Radiol; 2016 Mar; 57(3):348-55. PubMed ID: 25977576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI-based brain atrophy rates in ADNI phase 2: acceleration and enrichment considerations for clinical trials.
    Hua X; Ching CRK; Mezher A; Gutman BA; Hibar DP; Bhatt P; Leow AD; Jack CR; Bernstein MA; Weiner MW; Thompson PM;
    Neurobiol Aging; 2016 Jan; 37():26-37. PubMed ID: 26545631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studying ventricular abnormalities in mild cognitive impairment with hyperbolic Ricci flow and tensor-based morphometry.
    Shi J; Stonnington CM; Thompson PM; Chen K; Gutman B; Reschke C; Baxter LC; Reiman EM; Caselli RJ; Wang Y;
    Neuroimage; 2015 Jan; 104():1-20. PubMed ID: 25285374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unbiased tensor-based morphometry: improved robustness and sample size estimates for Alzheimer's disease clinical trials.
    Hua X; Hibar DP; Ching CR; Boyle CP; Rajagopalan P; Gutman BA; Leow AD; Toga AW; Jack CR; Harvey D; Weiner MW; Thompson PM;
    Neuroimage; 2013 Feb; 66():648-61. PubMed ID: 23153970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparison of Accelerated and Non-accelerated MRI Scans for Brain Volume and Boundary Shift Integral Measures of Volume Change: Evidence from the ADNI Dataset.
    Manning EN; Leung KK; Nicholas JM; Malone IB; Cardoso MJ; Schott JM; Fox NC; Barnes J;
    Neuroinformatics; 2017 Apr; 15(2):215-226. PubMed ID: 28316055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects.
    Hua X; Lee S; Yanovsky I; Leow AD; Chou YY; Ho AJ; Gutman B; Toga AW; Jack CR; Bernstein MA; Reiman EM; Harvey DJ; Kornak J; Schuff N; Alexander GE; Weiner MW; Thompson PM;
    Neuroimage; 2009 Dec; 48(4):668-81. PubMed ID: 19615450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does MRI scan acceleration affect power to track brain change?
    Ching CR; Hua X; Hibar DP; Ward CP; Gunter JL; Bernstein MA; Jack CR; Weiner MW; Thompson PM;
    Neurobiol Aging; 2015 Jan; 36 Suppl 1(0 1):S167-77. PubMed ID: 25444601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered amplitude of low-frequency fluctuations in early and late mild cognitive impairment and Alzheimer's disease.
    Liang P; Xiang J; Liang H; Qi Z; Li K; Alzheimer's Disease NeuroImaging Initiative
    Curr Alzheimer Res; 2014 May; 11(4):389-98. PubMed ID: 24720892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping Alzheimer's disease progression in 1309 MRI scans: power estimates for different inter-scan intervals.
    Hua X; Lee S; Hibar DP; Yanovsky I; Leow AD; Toga AW; Jack CR; Bernstein MA; Reiman EM; Harvey DJ; Kornak J; Schuff N; Alexander GE; Weiner MW; Thompson PM;
    Neuroimage; 2010 May; 51(1):63-75. PubMed ID: 20139010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth-Associated Protein 43 and Tensor-Based Morphometry Indices in Mild Cognitive Impairment.
    Seyedmirzaei H; Salmannezhad A; Ashayeri H; Shushtari A; Farazinia B; Heidari MM; Momayezi A; Shaki Baher S
    Neuroinformatics; 2024 Jul; 22(3):239-250. PubMed ID: 38630411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of gray matter microstructural changes in Alzheimer's disease continuum using fiber orientation.
    Lee P; Kim HR; Jeong Y;
    BMC Neurol; 2020 Oct; 20(1):362. PubMed ID: 33008321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI, and normal subjects.
    Hua X; Leow AD; Parikshak N; Lee S; Chiang MC; Toga AW; Jack CR; Weiner MW; Thompson PM;
    Neuroimage; 2008 Nov; 43(3):458-69. PubMed ID: 18691658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal changes in the brain in mild cognitive impairment: a magnetic resonance imaging study using the visual rating method and tensor-based morphometry.
    Tuokkola T; Koikkalainen J; Parkkola R; Karrasch M; Lötjönen J; Rinne JO
    Acta Radiol; 2018 Aug; 59(8):973-979. PubMed ID: 28952780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer's disease.
    Li X; Li TQ; Andreasen N; Wiberg MK; Westman E; Wahlund LO
    J Intern Med; 2014 Apr; 275(4):418-27. PubMed ID: 24237038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
    Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
    Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-template tensor-based morphometry: application to analysis of Alzheimer's disease.
    Koikkalainen J; Lötjönen J; Thurfjell L; Rueckert D; Waldemar G; Soininen H;
    Neuroimage; 2011 Jun; 56(3):1134-44. PubMed ID: 21419228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampal volume change measurement: quantitative assessment of the reproducibility of expert manual outlining and the automated methods FreeSurfer and FIRST.
    Mulder ER; de Jong RA; Knol DL; van Schijndel RA; Cover KS; Visser PJ; Barkhof F; Vrenken H;
    Neuroimage; 2014 May; 92():169-81. PubMed ID: 24521851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D characterization of brain atrophy in Alzheimer's disease and mild cognitive impairment using tensor-based morphometry.
    Hua X; Leow AD; Lee S; Klunder AD; Toga AW; Lepore N; Chou YY; Brun C; Chiang MC; Barysheva M; Jack CR; Bernstein MA; Britson PJ; Ward CP; Whitwell JL; Borowski B; Fleisher AS; Fox NC; Boyes RG; Barnes J; Harvey D; Kornak J; Schuff N; Boreta L; Alexander GE; Weiner MW; Thompson PM;
    Neuroimage; 2008 May; 41(1):19-34. PubMed ID: 18378167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive and neuroimaging profiles in mild cognitive impairment and Alzheimer's disease: data from the Spanish Multicenter Normative Studies (NEURONORMA Project).
    Sánchez-Benavides G; Peña-Casanova J; Casals-Coll M; Gramunt N; Molinuevo JL; Gómez-Ansón B; Aguilar M; Robles A; Antúnez C; Martínez-Parra C; Frank-García A; Fernández-Martínez M; Blesa R;
    J Alzheimers Dis; 2014; 41(3):887-901. PubMed ID: 24718100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.